In healthy women the drugs don't appear to save lives at all, and the evidence they prevent heart disease is weak: Statin takers have only a slightly better chance of avoiding heart disease than women on a placebo, according to a recent analysis.
Like most drugs, the key will be to differentiate them from known modalities (and other macrocycles), and this will fundamentally depend on a target-by-target, disease-by-disease analysis.
With a database of recordings available for analysis, more sophisticated algorithms could also be developed that may lead to a scoring system for disease progression based on voice alone.
Now a new analysis from a study funded by the National Institutes of Health seems to show Zetia works on the same measure of artery disease it flunked in ENHANCE.
This analysis says that it's not well established that food allergies are on the rise, although a recent Centers for Disease Control and Prevention report said that in the last decade, the number people with diagnosed food allergies had risen by 18 percent.